» Articles » PMID: 23221346

SMRT-GPS2 Corepressor Pathway Dysregulation Coincides with Obesity-linked Adipocyte Inflammation

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2012 Dec 11
PMID 23221346
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Low-grade chronic inflammation is a major characteristic of obesity and results from deregulated white adipose tissue function. Consequently, there is interest in identifying the underlying regulatory mechanisms and components that drive adipocyte inflammation. Here, we report that expression of the transcriptional corepressor complex subunits GPS2 and SMRT was significantly reduced in obese adipose tissue, inversely correlated to inflammatory status, and was restored upon gastric bypass surgery-induced weight loss in morbid obesity. These alterations correlated with reduced occupancy of the corepressor complex at inflammatory promoters, providing a mechanistic explanation for elevated inflammatory transcription. In support of these correlations, RNAi-mediated depletion of GPS2 and SMRT from cultured human adipocytes promoted derepression of inflammatory transcription and elevation of obesity-associated inflammatory markers, such as IL-6 and MCP-1. Furthermore, we identified a regulatory cascade containing PPARγ and TWIST1 that controlled the expression of GPS2 and SMRT in human adipocytes. These findings were clinically relevant, because treatment of diabetic obese patients with pioglitazone, an antidiabetic and antiinflammatory PPARγ agonist, restored expression of TWIST1, GPS2, and SMRT in adipose tissue. Collectively, our findings identify alterations in a regulatory transcriptional network in adipocytes involving the dysregulation of a specific corepressor complex as among the initiating events promoting adipose tissue inflammation in human obesity.

Citing Articles

GPS2 promotes erythroid differentiation in K562 erythroleukemia cells primarily via NCOR1.

Lu Y, Ma W, Ren G, Li Y, Wang T, Zhan Y Int J Hematol. 2024; 120(2):157-166.

PMID: 38814500 DOI: 10.1007/s12185-024-03797-x.


GPS2 ameliorates cigarette smoking-induced pulmonary vascular remodeling by modulating the ras-Raf-ERK axis.

Hu T, Mu C, Li Y, Hao W, Yu X, Wang Y Respir Res. 2024; 25(1):210.

PMID: 38755610 PMC: 11100185. DOI: 10.1186/s12931-024-02831-0.


Roles of Twist1 in lipid and glucose metabolism.

Huang L, Xing Y, Ning X, Yu Z, Bai X, Liu L Cell Commun Signal. 2023; 21(1):270.

PMID: 37784111 PMC: 10544448. DOI: 10.1186/s12964-023-01262-6.


Revisiting the Mesenchymal "Stem vs. Stromal" Cell Dichotomy and Its Implications for Development of Improved Potency Metrics.

Phinney D, Lee R, Boregowda S Stem Cells. 2023; 41(5):444-452.

PMID: 36891977 PMC: 10183967. DOI: 10.1093/stmcls/sxad019.


Targeting 3D chromosomal architecture at the RANK loci to suppress myeloma-driven osteoclastogenesis.

Thummler K, Williams M, Kitson S, Sood S, Akbar M, Cole J Oncoimmunology. 2022; 11(1):2104070.

PMID: 35936985 PMC: 9348127. DOI: 10.1080/2162402X.2022.2104070.


References
1.
Glass C, Olefsky J . Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab. 2012; 15(5):635-45. PMC: 4156155. DOI: 10.1016/j.cmet.2012.04.001. View

2.
Tsou C, Peters W, Si Y, Slaymaker S, Aslanian A, Weisberg S . Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J Clin Invest. 2007; 117(4):902-9. PMC: 1810572. DOI: 10.1172/JCI29919. View

3.
Maury E, Brichard S . Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol. 2009; 314(1):1-16. DOI: 10.1016/j.mce.2009.07.031. View

4.
Rosenfeld M, Lunyak V, Glass C . Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev. 2006; 20(11):1405-28. DOI: 10.1101/gad.1424806. View

5.
Wellen K, Hotamisligil G . Obesity-induced inflammatory changes in adipose tissue. J Clin Invest. 2003; 112(12):1785-8. PMC: 297006. DOI: 10.1172/JCI20514. View